The U.S. federal government has recently awarded the following notable contract related to the field of chemical, biological, radiological and nuclear (CBRN) medical countermeasures:
Meridian Medical Technologies, Columbia, Maryland, has been awarded a maximum $129,537,132 modification (P00102) exercising the fourth option year to one-year base contract SPM2DP-11-D-0002 with four one-year option periods for nerve agent antidotes in auto-injectors.
This is a firm-fixed-price, indefinite-quantity contract. Locations of performance are Maryland and Missouri with a Dec. 31, 2015, performance completion date. Using military services are Army, Navy, Air Force, and Marine Corps. Type of appropriation is fiscal 2015 war-stopper funds. The contracting activity is the Defense Logistics Agency Troop Support, Philadelphia, Pennsylvania.
